EMVision Medical Devices (ASX:EMV) - Aandelenkoers, Nieuws & Analyse

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

EMV Overzicht aandelen

EMVision Medical Devices Ltd houdt zich bezig met onderzoek, ontwikkeling en verkoop van neurodiagnostische technologie voor diagnose en bewaking van beroertes en andere behoeften op het gebied van medische beeldvorming in Australië.

Over het bedrijf

EMV fundamentele analyse
Sneeuwvlok Score
Waardering	1/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	5/6
Dividenden	0/6

Beloningen

De winst is de afgelopen 5 jaar met 0.7% per jaar gegroeid

Risicoanalyse

Aandeelhouders zijn het afgelopen jaar verwaterd

EMVision Medical Devices Ltd Concurrenten

Cyclopharm

ASX:CYC

AU$188.9m

Optiscan Imaging

ASX:OIL

AU$133.7m

Austco Healthcare

ASX:AHC

AU$91.0m

ImpediMed

ASX:IPD

AU$117.3m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor EMVision Medical Devices
Historische aandelenkoersen
Huidige aandelenkoers	AU$2.00
52 Week Hoogtepunt	AU$2.72
52 Week Laag	AU$1.45
Bèta	1.47
11 maand verandering	-3.38%
3 maanden verandering	0%
1 Jaar Verandering	25.00%
33 jaar verandering	-32.20%
5 jaar verandering	127.27%
Verandering sinds IPO	555.74%

Recent nieuws en updates

EMVision Medical Devices (ASX:EMV) Is Using Debt Safely

Aug 28

Recent updates

EMVision Medical Devices (ASX:EMV) Is Using Debt Safely

Aug 28

Is EMVision Medical Devices (ASX:EMV) A Risky Investment?

Nov 21

Here's Why We're Not At All Concerned With EMVision Medical Devices' (ASX:EMV) Cash Burn Situation

Apr 24

EMVision Medical Devices Ltd's (ASX:EMV) CEO Compensation Is Looking A Bit Stretched At The Moment

Nov 09

We're Not Very Worried About EMVision Medical Devices' (ASX:EMV) Cash Burn Rate

Oct 04

Companies Like EMvision Medical Devices (ASX:EMV) Are In A Position To Invest In Growth

Jun 17

Here's Why We're Not Too Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Situation

Feb 22

Investors Who Bought EMvision Medical Devices (ASX:EMV) Shares A Year Ago Are Now Up 319%

Dec 20

We Think EMvision Medical Devices (ASX:EMV) Can Afford To Drive Business Growth

Nov 24

Rendement voor aandeelhouders

	EMV	AU Medical Equipment	AU Markt
7D	-2.9%	0.4%	-0.2%
1Y	25.0%	15.5%	15.5%

Rendement versus industrie: EMV overtrof de Australian Medical Equipment industrie, die het afgelopen jaar een rendement 16.5 % opleverde.

Rendement versus markt: EMV overtrof de Australian markt, die het afgelopen jaar een rendement opleverde van 17.9 %.

Prijsvolatiliteit

Is EMV's price volatile compared to industry and market?
EMV volatility
EMV Average Weekly Movement	6.7%
Medical Equipment Industry Average Movement	10.0%
Market Average Movement	8.8%
10% most volatile stocks in AU Market	17.3%
10% least volatile stocks in AU Market	3.6%

Stabiele aandelenkoers: EMV heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 7% ) van EMV is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2017	n/a	Scott Kirkland	www.emvision.com.au

EMVision Medical Devices Ltd houdt zich bezig met onderzoek, ontwikkeling en verkoop van neurodiagnostische technologie voor diagnose en bewaking van beroertes en andere medische beeldvorming in Australië. Het bedrijf biedt niet-invasieve hersenscanners bedside apparaat emu, een ultra-lichtgewicht first responder pre-hospital apparaat. EMVision Medical Devices Ltd werd opgericht in 2017 en is gevestigd in Macquarie Park, Australië.

EMVision Medical Devices Ltd Samenvatting

Hoe verhouden de winst en inkomsten van EMVision Medical Devices zich tot de beurswaarde?
EMV fundamentele statistieken
Marktkapitalisatie	AU$171.03m
Inkomsten(TTM)	-AU$2.73m
Inkomsten(TTM)	AU$11.22m

15.2x

P/S-verhouding

-62.7x

Koers/Winstverhouding

Is EMV overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
EMV resultatenrekening (TTM)
Inkomsten	AU$11.22m
Kosten van inkomsten	AU$0
Brutowinst	AU$11.22m
Overige uitgaven	AU$13.95m
Inkomsten	-AU$2.73m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.032
Brutomarge	100.00%
Nettowinstmarge	-24.33%
Schuld/Eigen Vermogen Verhouding	14.0%

Hoe presteerde EMV op de lange termijn?

Bekijk historische prestaties en vergelijking

EMV Overzicht aandelen

Beloningen

Risicoanalyse

EMVision Medical Devices Ltd Concurrenten

ASX:CYC

AU$188.9m

ASX:OIL

AU$133.7m

ASX:AHC

AU$91.0m

ASX:IPD

AU$117.3m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

EMVision Medical Devices (ASX:EMV) Is Using Debt Safely

Full year 2024 earnings released: AU$0.034 loss per share (vs AU$0.05 loss in FY 2023)

EMVision Unveils Backpack-Sized Brain Scanner to Empower First Responders

New minor risk - Shareholder dilution

New minor risk - Shareholder dilution

EMVision Medical Devices Ltd has filed a Follow-on Equity Offering in the amount of AUD 15.281174 million.

Recent updates

EMVision Medical Devices (ASX:EMV) Is Using Debt Safely

Full year 2024 earnings released: AU$0.034 loss per share (vs AU$0.05 loss in FY 2023)

EMVision Unveils Backpack-Sized Brain Scanner to Empower First Responders

New minor risk - Shareholder dilution

New minor risk - Shareholder dilution

EMVision Medical Devices Ltd has filed a Follow-on Equity Offering in the amount of AUD 15.281174 million.

EMVision Medical Devices Ltd has completed a Follow-on Equity Offering in the amount of AUD 15.281174 million.

EMVision Medical Devices Ltd announced that it expects to receive AUD 15.281174 million in funding from Keysight Technologies, Inc.

Is EMVision Medical Devices (ASX:EMV) A Risky Investment?

EMVision Medical Devices Ltd, Annual General Meeting, Nov 15, 2023

Full year 2023 earnings released: AU$0.05 loss per share (vs AU$0.081 loss in FY 2022)

New minor risk - Financial data availability

Emvision Medical Devices Limited Receives $1.75 Million Manufacturing Grant Award

Here's Why We're Not At All Concerned With EMVision Medical Devices' (ASX:EMV) Cash Burn Situation

No longer forecast to breakeven

EMVision Medical Devices Limited Provides an Update on Its Clinical Trial and Achievement of an Important Technical Development Milestone

EMVision Commences Clinical Trial

Less than half of directors are independent

EMVision Medical Devices Ltd Announces its Portable Brain Scanner Delivered to First Clinical Site

EMVision Medical Devices Ltd's (ASX:EMV) CEO Compensation Is Looking A Bit Stretched At The Moment

We're Not Very Worried About EMVision Medical Devices' (ASX:EMV) Cash Burn Rate

EMVision Medical Devices Ltd, Annual General Meeting, Nov 16, 2022

Full year 2022 earnings released: AU$0.081 loss per share (vs AU$0.12 loss in FY 2021)

Companies Like EMvision Medical Devices (ASX:EMV) Are In A Position To Invest In Growth

Less than half of directors are independent

EMvision Medical Devices Limited Announces Clinical Advisory Board Appointments

We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

CEO, MD & Director exercised options to buy AU$2.3m worth of stock.

We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

Full year 2021 earnings released: AU$0.12 loss per share (vs AU$0.057 loss in FY 2020)

EMvision Medical Devices Limited provides an update on the build of its First Gen device

We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

Medical Devices Limited Announces Australian Stroke Alliance in Collaboration with EMVision Wins Stage 2 MRFF Bid

Here's Why We're Not Too Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Situation

New 90-day low: AU$2.70

EMvision Medical Devices Limited Announces FDA Provides De Novo Guidance

New 90-day low: AU$2.71

EMvision Medical Devices Limited Submits 513(G) Request for Information to the United States Food and Drug Administration

Investors Who Bought EMvision Medical Devices (ASX:EMV) Shares A Year Ago Are Now Up 319%

EMVision Medical Devices Limited Appoints Stuart Crozier as Chief Scientific Officer

We Think EMvision Medical Devices (ASX:EMV) Can Afford To Drive Business Growth

New 90-day high: AU$3.01

EMvision Medical Devices Limited Announces Board Changes

New 90-day high - AU$2.35

Full year earnings released - AU$0.056 loss per share

New 90-day high - AU$1.90

Rendement voor aandeelhouders

Prijsvolatiliteit

Over het bedrijf

EMVision Medical Devices Ltd Samenvatting

15.2x

-62.7x

Inkomsten en omzet